Postby Rock_Robster » Fri Aug 02, 2019 11:38 pm
I am by no means an expert on the US health insurance system, but I’ve heard that sometimes asking your oncologist to make a “peer-to-peer” call to the insurance company’s medicos can help. If they’ve decided to stop funding that particular chemo regime because they consider it ineffective (i.e. showed progression), but your oncologist still wishes to give it, then he should have a rationale as to why he thinks it’s still potentially beneficial which he could explain to them?
41M Australia
2018 Dx RC
G2 EMVI LVI, 4 liver mets
pT3N1aM1a Stage IVa MSS NRAS G13R
CEA 14>2>32>16>19>30>140>70
11/18 FOLFOX
3/19 Liver resection
5/19 Pelvic IMRT
7/19 ULAR
8/19 Liver met
8/19 FOLFOX, FOLFOXIRI, FOLFIRI
12/19 Liver resection
NED 2 years
11/21 Liver met, PALN, lung nodules
3/22 PVE, lymphadenectomy, liver SBRT
10/22 PALN SBRT
11/22 Liver mets, peri nodule. Xeloda+Bev
4/23 XELIRI+Bev
9/23 ATRIUM trial
12/23 Modified FOLFIRI+Bev
3/24 VAXINIA (CF33 + hNIS) trial